Authors: Dangge Wang, Tingting Wang, Haijun Yu, Bing Feng, Lei Zhou, Fangyuan Zhou, Bo Hou, Hanwu Zhang, Min Luo, Yaping Li
Published: 2019-07-12
DOI: 10.1126/sciimmunol.aau6584
Source: Full article
Engineered antibody nanoparticles overcome immunological tolerance to PDL1 blockade therapy.